<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00263133</url>
  </required_header>
  <id_info>
    <org_study_id>VEP-1</org_study_id>
    <secondary_id>EudraCT 2005-005417-37</secondary_id>
    <nct_id>NCT00263133</nct_id>
  </id_info>
  <brief_title>Modulation of Visually Evoked Potentials by an Antidepressant</brief_title>
  <official_title>Modulation of Visually Evoked Potentials by an Antidepressant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Freiburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Freiburg</source>
  <brief_summary>
    <textblock>
      12 normal healthy controls will be treated with 50 mg sertraline once daily for three weeks.
      Early amplitudes of visually evoked potentials will be examined at day 0, 10 and 21 and
      statistically compared. This study aims to examine a putative modulation of synaptic
      transmission and plasticity by an antidepressant and is part of a series of studies in
      healthy individuals and depressed patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date>January 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amplitudes and latencies of early visually evoked potentials.</measure>
  </primary_outcome>
  <enrollment>12</enrollment>
  <condition>Depression</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sertraline</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy individuals 18-65 years

        Exclusion Criteria:

          -  history of affective oder other psyhiatric disorder

          -  severe medical condition

          -  pregnancy or ineffective contraception

          -  active illicit drug use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claus Normann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Psychiatry, University of Freiburg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of Psychiatry, University of Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79104</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2005</study_first_submitted>
  <study_first_submitted_qc>December 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2005</study_first_posted>
  <last_update_submitted>June 1, 2007</last_update_submitted>
  <last_update_submitted_qc>June 1, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2007</last_update_posted>
  <keyword>Depression</keyword>
  <keyword>SSRI</keyword>
  <keyword>Sertraline</keyword>
  <keyword>synaptic plasticity</keyword>
  <keyword>visually evoked potentials</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antidepressive Agents</mesh_term>
    <mesh_term>Sertraline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

